nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—Multi-organ failure—Vincristine—colon cancer	0.0497	0.0534	CcSEcCtD
Cinacalcet—Thrombosis—Irinotecan—colon cancer	0.0223	0.0239	CcSEcCtD
Cinacalcet—Neoplasm malignant—Irinotecan—colon cancer	0.0185	0.0199	CcSEcCtD
Cinacalcet—Floctafenine—PTGS2—colon cancer	0.0174	0.579	CrCbGaD
Cinacalcet—Hypercalcaemia—Capecitabine—colon cancer	0.0152	0.0163	CcSEcCtD
Cinacalcet—Thrombosis—Capecitabine—colon cancer	0.0149	0.016	CcSEcCtD
Cinacalcet—Multiple fractures—Methotrexate—colon cancer	0.0135	0.0145	CcSEcCtD
Cinacalcet—Fracture—Methotrexate—colon cancer	0.0135	0.0145	CcSEcCtD
Cinacalcet—Pain in extremity—Vincristine—colon cancer	0.0118	0.0126	CcSEcCtD
Cinacalcet—Hypocalcaemia—Capecitabine—colon cancer	0.0115	0.0124	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.0115	0.0123	CcSEcCtD
Cinacalcet—Cardiac failure—Fluorouracil—colon cancer	0.0112	0.0121	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.011	0.0118	CcSEcCtD
Cinacalcet—Dehydration—Vincristine—colon cancer	0.0109	0.0117	CcSEcCtD
Cinacalcet—Dehydration—Irinotecan—colon cancer	0.0107	0.0114	CcSEcCtD
Cinacalcet—Cramp muscle—Irinotecan—colon cancer	0.0103	0.0111	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Irinotecan—colon cancer	0.0092	0.00988	CcSEcCtD
Cinacalcet—Depression—Vincristine—colon cancer	0.00904	0.00971	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00881	0.00947	CcSEcCtD
Cinacalcet—Bone disorder—Methotrexate—colon cancer	0.0087	0.00935	CcSEcCtD
Cinacalcet—Cardiac failure—Capecitabine—colon cancer	0.00786	0.00844	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00767	0.00824	CcSEcCtD
Cinacalcet—Pain in extremity—Capecitabine—colon cancer	0.00767	0.00824	CcSEcCtD
Cinacalcet—Immune system disorder—Irinotecan—colon cancer	0.00716	0.00769	CcSEcCtD
Cinacalcet—Dehydration—Capecitabine—colon cancer	0.00713	0.00766	CcSEcCtD
Cinacalcet—Arrhythmia—Irinotecan—colon cancer	0.00708	0.0076	CcSEcCtD
Cinacalcet—Arrhythmia—Fluorouracil—colon cancer	0.00678	0.00728	CcSEcCtD
Cinacalcet—Muscle spasms—Irinotecan—colon cancer	0.00663	0.00712	CcSEcCtD
Cinacalcet—Anaemia—Vincristine—colon cancer	0.00655	0.00703	CcSEcCtD
Cinacalcet—Anaemia—Irinotecan—colon cancer	0.00638	0.00685	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Capecitabine—colon cancer	0.00616	0.00661	CcSEcCtD
Cinacalcet—Convulsion—Vincristine—colon cancer	0.00614	0.00659	CcSEcCtD
Cinacalcet—Hypertension—Vincristine—colon cancer	0.00612	0.00657	CcSEcCtD
Cinacalcet—Anaemia—Fluorouracil—colon cancer	0.00611	0.00656	CcSEcCtD
Cinacalcet—Myalgia—Vincristine—colon cancer	0.00603	0.00648	CcSEcCtD
Cinacalcet—Cough—Irinotecan—colon cancer	0.00602	0.00647	CcSEcCtD
Cinacalcet—Hypertension—Irinotecan—colon cancer	0.00596	0.0064	CcSEcCtD
Cinacalcet—Depression—Capecitabine—colon cancer	0.00589	0.00633	CcSEcCtD
Cinacalcet—Infection—Vincristine—colon cancer	0.00574	0.00617	CcSEcCtD
Cinacalcet—Convulsion—Fluorouracil—colon cancer	0.00572	0.00615	CcSEcCtD
Cinacalcet—Nervous system disorder—Vincristine—colon cancer	0.00567	0.00609	CcSEcCtD
Cinacalcet—Chest pain—Fluorouracil—colon cancer	0.00562	0.00604	CcSEcCtD
Cinacalcet—Myalgia—Fluorouracil—colon cancer	0.00562	0.00604	CcSEcCtD
Cinacalcet—Infection—Irinotecan—colon cancer	0.00559	0.00601	CcSEcCtD
Cinacalcet—Nervous system disorder—Irinotecan—colon cancer	0.00552	0.00593	CcSEcCtD
Cinacalcet—Anorexia—Vincristine—colon cancer	0.00551	0.00592	CcSEcCtD
Cinacalcet—Hypotension—Vincristine—colon cancer	0.0054	0.0058	CcSEcCtD
Cinacalcet—Anorexia—Irinotecan—colon cancer	0.00537	0.00576	CcSEcCtD
Cinacalcet—Infection—Fluorouracil—colon cancer	0.00536	0.00575	CcSEcCtD
Cinacalcet—Nervous system disorder—Fluorouracil—colon cancer	0.00529	0.00568	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Vincristine—colon cancer	0.00527	0.00566	CcSEcCtD
Cinacalcet—Hypotension—Irinotecan—colon cancer	0.00526	0.00565	CcSEcCtD
Cinacalcet—Oedema peripheral—Capecitabine—colon cancer	0.00522	0.00561	CcSEcCtD
Cinacalcet—Fluoxetine—ABCB1—colon cancer	0.00522	0.174	CrCbGaD
Cinacalcet—Paraesthesia—Vincristine—colon cancer	0.00519	0.00558	CcSEcCtD
Cinacalcet—Anorexia—Fluorouracil—colon cancer	0.00514	0.00552	CcSEcCtD
Cinacalcet—Paraesthesia—Irinotecan—colon cancer	0.00506	0.00543	CcSEcCtD
Cinacalcet—Hypotension—Fluorouracil—colon cancer	0.00504	0.00541	CcSEcCtD
Cinacalcet—Decreased appetite—Vincristine—colon cancer	0.00503	0.0054	CcSEcCtD
Cinacalcet—Dyspnoea—Irinotecan—colon cancer	0.00502	0.00539	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Vincristine—colon cancer	0.00499	0.00536	CcSEcCtD
Cinacalcet—Fatigue—Vincristine—colon cancer	0.00498	0.00535	CcSEcCtD
Cinacalcet—Dyspepsia—Irinotecan—colon cancer	0.00496	0.00532	CcSEcCtD
Cinacalcet—Constipation—Vincristine—colon cancer	0.00494	0.00531	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00491	0.00528	CcSEcCtD
Cinacalcet—Decreased appetite—Irinotecan—colon cancer	0.00489	0.00526	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Irinotecan—colon cancer	0.00486	0.00522	CcSEcCtD
Cinacalcet—Fatigue—Irinotecan—colon cancer	0.00485	0.00521	CcSEcCtD
Cinacalcet—Paraesthesia—Fluorouracil—colon cancer	0.00484	0.0052	CcSEcCtD
Cinacalcet—Constipation—Irinotecan—colon cancer	0.00481	0.00517	CcSEcCtD
Cinacalcet—Dyspnoea—Fluorouracil—colon cancer	0.00481	0.00516	CcSEcCtD
Cinacalcet—Immune system disorder—Capecitabine—colon cancer	0.00479	0.00515	CcSEcCtD
Cinacalcet—Dyspepsia—Fluorouracil—colon cancer	0.00475	0.0051	CcSEcCtD
Cinacalcet—Arrhythmia—Capecitabine—colon cancer	0.00474	0.00509	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Vincristine—colon cancer	0.00473	0.00508	CcSEcCtD
Cinacalcet—Decreased appetite—Fluorouracil—colon cancer	0.00469	0.00503	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00466	0.005	CcSEcCtD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—CDH1—colon cancer	0.00464	0.128	CbGpPWpGaD
Cinacalcet—Malnutrition—Capecitabine—colon cancer	0.00462	0.00496	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Irinotecan—colon cancer	0.0046	0.00495	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Methotrexate—colon cancer	0.00458	0.00492	CcSEcCtD
Cinacalcet—Abdominal pain—Vincristine—colon cancer	0.00457	0.00491	CcSEcCtD
Cinacalcet—Body temperature increased—Vincristine—colon cancer	0.00457	0.00491	CcSEcCtD
Cinacalcet—Body temperature increased—Irinotecan—colon cancer	0.00445	0.00478	CcSEcCtD
Cinacalcet—Abdominal pain—Irinotecan—colon cancer	0.00445	0.00478	CcSEcCtD
Cinacalcet—Muscle spasms—Capecitabine—colon cancer	0.00444	0.00477	CcSEcCtD
Cinacalcet—Depression—Methotrexate—colon cancer	0.00439	0.00471	CcSEcCtD
Cinacalcet—Urticaria—Fluorouracil—colon cancer	0.00428	0.0046	CcSEcCtD
Cinacalcet—Anaemia—Capecitabine—colon cancer	0.00427	0.00458	CcSEcCtD
Cinacalcet—Body temperature increased—Fluorouracil—colon cancer	0.00426	0.00458	CcSEcCtD
Cinacalcet—Triflupromazine—ABCB1—colon cancer	0.00426	0.142	CrCbGaD
Cinacalcet—Hypersensitivity—Vincristine—colon cancer	0.00426	0.00458	CcSEcCtD
Cinacalcet—Hypersensitivity—Irinotecan—colon cancer	0.00415	0.00446	CcSEcCtD
Cinacalcet—Asthenia—Vincristine—colon cancer	0.00415	0.00446	CcSEcCtD
Cinacalcet—Asthenia—Irinotecan—colon cancer	0.00404	0.00434	CcSEcCtD
Cinacalcet—Cough—Capecitabine—colon cancer	0.00403	0.00433	CcSEcCtD
Cinacalcet—Hypertension—Capecitabine—colon cancer	0.00399	0.00428	CcSEcCtD
Cinacalcet—Hypersensitivity—Fluorouracil—colon cancer	0.00397	0.00427	CcSEcCtD
Cinacalcet—Diarrhoea—Vincristine—colon cancer	0.00396	0.00425	CcSEcCtD
Cinacalcet—Arthralgia—Capecitabine—colon cancer	0.00393	0.00422	CcSEcCtD
Cinacalcet—Myalgia—Capecitabine—colon cancer	0.00393	0.00422	CcSEcCtD
Cinacalcet—Chest pain—Capecitabine—colon cancer	0.00393	0.00422	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.0039	0.00419	CcSEcCtD
Cinacalcet—Diarrhoea—Irinotecan—colon cancer	0.00385	0.00414	CcSEcCtD
Cinacalcet—Dizziness—Vincristine—colon cancer	0.00382	0.00411	CcSEcCtD
Cinacalcet—Pruritus—Fluorouracil—colon cancer	0.00381	0.0041	CcSEcCtD
Cinacalcet—Infection—Capecitabine—colon cancer	0.00374	0.00402	CcSEcCtD
Cinacalcet—Dizziness—Irinotecan—colon cancer	0.00372	0.004	CcSEcCtD
Cinacalcet—Nervous system disorder—Capecitabine—colon cancer	0.0037	0.00397	CcSEcCtD
Cinacalcet—Diarrhoea—Fluorouracil—colon cancer	0.00369	0.00396	CcSEcCtD
Cinacalcet—Vomiting—Vincristine—colon cancer	0.00368	0.00395	CcSEcCtD
Cinacalcet—Skin disorder—Capecitabine—colon cancer	0.00366	0.00393	CcSEcCtD
Cinacalcet—Rash—Vincristine—colon cancer	0.00365	0.00392	CcSEcCtD
Cinacalcet—Dermatitis—Vincristine—colon cancer	0.00364	0.00391	CcSEcCtD
Cinacalcet—Headache—Vincristine—colon cancer	0.00362	0.00389	CcSEcCtD
Cinacalcet—Anorexia—Capecitabine—colon cancer	0.00359	0.00386	CcSEcCtD
Cinacalcet—Vomiting—Irinotecan—colon cancer	0.00358	0.00385	CcSEcCtD
Cinacalcet—Immune system disorder—Methotrexate—colon cancer	0.00357	0.00383	CcSEcCtD
Cinacalcet—Dizziness—Fluorouracil—colon cancer	0.00357	0.00383	CcSEcCtD
Cinacalcet—Rash—Irinotecan—colon cancer	0.00355	0.00381	CcSEcCtD
Cinacalcet—Dermatitis—Irinotecan—colon cancer	0.00355	0.00381	CcSEcCtD
Cinacalcet—Headache—Irinotecan—colon cancer	0.00353	0.00379	CcSEcCtD
Cinacalcet—Hypotension—Capecitabine—colon cancer	0.00352	0.00378	CcSEcCtD
Cinacalcet—Malnutrition—Methotrexate—colon cancer	0.00344	0.00369	CcSEcCtD
Cinacalcet—Nausea—Vincristine—colon cancer	0.00343	0.00369	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00343	0.00369	CcSEcCtD
Cinacalcet—Vomiting—Fluorouracil—colon cancer	0.00343	0.00368	CcSEcCtD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—CTNNB1—colon cancer	0.00342	0.0948	CbGpPWpGaD
Cinacalcet—Rash—Fluorouracil—colon cancer	0.0034	0.00365	CcSEcCtD
Cinacalcet—Dermatitis—Fluorouracil—colon cancer	0.0034	0.00365	CcSEcCtD
Cinacalcet—Paraesthesia—Capecitabine—colon cancer	0.00338	0.00363	CcSEcCtD
Cinacalcet—Headache—Fluorouracil—colon cancer	0.00338	0.00363	CcSEcCtD
Cinacalcet—Dyspnoea—Capecitabine—colon cancer	0.00336	0.00361	CcSEcCtD
Cinacalcet—Nausea—Irinotecan—colon cancer	0.00334	0.00359	CcSEcCtD
Cinacalcet—Dyspepsia—Capecitabine—colon cancer	0.00332	0.00356	CcSEcCtD
Cinacalcet—Decreased appetite—Capecitabine—colon cancer	0.00328	0.00352	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Capecitabine—colon cancer	0.00325	0.00349	CcSEcCtD
Cinacalcet—Fatigue—Capecitabine—colon cancer	0.00325	0.00349	CcSEcCtD
Cinacalcet—Constipation—Capecitabine—colon cancer	0.00322	0.00346	CcSEcCtD
Cinacalcet—Nausea—Fluorouracil—colon cancer	0.0032	0.00344	CcSEcCtD
Cinacalcet—Propranolol—ABCB1—colon cancer	0.00318	0.106	CrCbGaD
Cinacalcet—Anaemia—Methotrexate—colon cancer	0.00318	0.00341	CcSEcCtD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—SRC—colon cancer	0.00309	0.0857	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Capecitabine—colon cancer	0.00308	0.00331	CcSEcCtD
Cinacalcet—Cough—Methotrexate—colon cancer	0.003	0.00322	CcSEcCtD
Cinacalcet—Urticaria—Capecitabine—colon cancer	0.00299	0.00322	CcSEcCtD
Cinacalcet—Abdominal pain—Capecitabine—colon cancer	0.00298	0.0032	CcSEcCtD
Cinacalcet—Body temperature increased—Capecitabine—colon cancer	0.00298	0.0032	CcSEcCtD
Cinacalcet—Convulsion—Methotrexate—colon cancer	0.00298	0.0032	CcSEcCtD
Cinacalcet—Chest pain—Methotrexate—colon cancer	0.00293	0.00314	CcSEcCtD
Cinacalcet—Myalgia—Methotrexate—colon cancer	0.00293	0.00314	CcSEcCtD
Cinacalcet—Arthralgia—Methotrexate—colon cancer	0.00293	0.00314	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00291	0.00312	CcSEcCtD
Cinacalcet—Infection—Methotrexate—colon cancer	0.00279	0.00299	CcSEcCtD
Cinacalcet—Hypersensitivity—Capecitabine—colon cancer	0.00278	0.00298	CcSEcCtD
Cinacalcet—Nervous system disorder—Methotrexate—colon cancer	0.00275	0.00295	CcSEcCtD
Cinacalcet—Skin disorder—Methotrexate—colon cancer	0.00272	0.00293	CcSEcCtD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—EGFR—colon cancer	0.00271	0.0751	CbGpPWpGaD
Cinacalcet—Asthenia—Capecitabine—colon cancer	0.0027	0.0029	CcSEcCtD
Cinacalcet—Anorexia—Methotrexate—colon cancer	0.00267	0.00287	CcSEcCtD
Cinacalcet—Pruritus—Capecitabine—colon cancer	0.00267	0.00286	CcSEcCtD
Cinacalcet—Hypotension—Methotrexate—colon cancer	0.00262	0.00282	CcSEcCtD
Cinacalcet—Diarrhoea—Capecitabine—colon cancer	0.00258	0.00277	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00256	0.00275	CcSEcCtD
Cinacalcet—Paraesthesia—Methotrexate—colon cancer	0.00252	0.00271	CcSEcCtD
Cinacalcet—Dyspnoea—Methotrexate—colon cancer	0.0025	0.00269	CcSEcCtD
Cinacalcet—Dizziness—Capecitabine—colon cancer	0.00249	0.00268	CcSEcCtD
Cinacalcet—Dyspepsia—Methotrexate—colon cancer	0.00247	0.00265	CcSEcCtD
Cinacalcet—Decreased appetite—Methotrexate—colon cancer	0.00244	0.00262	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Methotrexate—colon cancer	0.00242	0.0026	CcSEcCtD
Cinacalcet—Fatigue—Methotrexate—colon cancer	0.00242	0.0026	CcSEcCtD
Cinacalcet—Vomiting—Capecitabine—colon cancer	0.0024	0.00257	CcSEcCtD
Cinacalcet—Rash—Capecitabine—colon cancer	0.00238	0.00255	CcSEcCtD
Cinacalcet—Dermatitis—Capecitabine—colon cancer	0.00237	0.00255	CcSEcCtD
Cinacalcet—Headache—Capecitabine—colon cancer	0.00236	0.00254	CcSEcCtD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—PIK3CA—colon cancer	0.00235	0.0652	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Methotrexate—colon cancer	0.00229	0.00246	CcSEcCtD
Cinacalcet—Nausea—Capecitabine—colon cancer	0.00224	0.0024	CcSEcCtD
Cinacalcet—Urticaria—Methotrexate—colon cancer	0.00223	0.00239	CcSEcCtD
Cinacalcet—Abdominal pain—Methotrexate—colon cancer	0.00222	0.00238	CcSEcCtD
Cinacalcet—Body temperature increased—Methotrexate—colon cancer	0.00222	0.00238	CcSEcCtD
Cinacalcet—Hypersensitivity—Methotrexate—colon cancer	0.00207	0.00222	CcSEcCtD
Cinacalcet—Asthenia—Methotrexate—colon cancer	0.00201	0.00216	CcSEcCtD
Cinacalcet—Pruritus—Methotrexate—colon cancer	0.00198	0.00213	CcSEcCtD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—AKT1—colon cancer	0.00192	0.0533	CbGpPWpGaD
Cinacalcet—Diarrhoea—Methotrexate—colon cancer	0.00192	0.00206	CcSEcCtD
Cinacalcet—Dizziness—Methotrexate—colon cancer	0.00185	0.00199	CcSEcCtD
Cinacalcet—Vomiting—Methotrexate—colon cancer	0.00178	0.00192	CcSEcCtD
Cinacalcet—Rash—Methotrexate—colon cancer	0.00177	0.0019	CcSEcCtD
Cinacalcet—Dermatitis—Methotrexate—colon cancer	0.00177	0.0019	CcSEcCtD
Cinacalcet—Headache—Methotrexate—colon cancer	0.00176	0.00189	CcSEcCtD
Cinacalcet—Nausea—Methotrexate—colon cancer	0.00167	0.00179	CcSEcCtD
Cinacalcet—CYP2D6—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00136	0.0378	CbGpPWpGaD
Cinacalcet—CASR—renal system—colon cancer	0.00113	0.391	CbGeAlD
Cinacalcet—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	0.000952	0.0264	CbGpPWpGaD
Cinacalcet—CASR—digestive system—colon cancer	0.000926	0.321	CbGeAlD
Cinacalcet—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000892	0.0247	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CHST4—colon cancer	0.000807	0.0223	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—DLC1—colon cancer	0.000748	0.0207	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—LGR5—colon cancer	0.000703	0.0195	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000623	0.0172	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AXIN2—colon cancer	0.000505	0.014	CbGpPWpGaD
Cinacalcet—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000488	0.0135	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	0.000463	0.0128	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	0.000437	0.0121	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	0.000422	0.0117	CbGpPWpGaD
Cinacalcet—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000411	0.0114	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—PIK3CA—colon cancer	0.000409	0.0113	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	0.000399	0.011	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	0.00037	0.0103	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	0.000366	0.0101	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000363	0.0101	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	0.000339	0.00938	CbGpPWpGaD
Cinacalcet—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000294	0.00815	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000286	0.00792	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00028	0.00776	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.00027	0.00747	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000253	0.007	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000195	0.0054	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.000156	0.00432	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FGFR3—colon cancer	0.000146	0.00404	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	0.000146	0.00404	CbGpPWpGaD
Cinacalcet—CYP1A2—renal system—colon cancer	0.00014	0.0486	CbGeAlD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000136	0.00378	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—APC—colon cancer	0.000134	0.00371	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—NRAS—colon cancer	0.000134	0.00371	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.00013	0.00359	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.00013	0.00359	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000126	0.00349	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000126	0.00349	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—BRAF—colon cancer	0.000126	0.00349	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CA7—colon cancer	0.000125	0.00347	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000123	0.0034	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—EGFR—colon cancer	0.000122	0.00338	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000121	0.00336	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CA—colon cancer	0.000117	0.00323	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—KRAS—colon cancer	0.000115	0.00319	CbGpPWpGaD
Cinacalcet—CYP1A2—digestive system—colon cancer	0.000115	0.0399	CbGeAlD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000113	0.00313	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000113	0.00312	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000111	0.00306	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000111	0.00306	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CA7—colon cancer	0.000106	0.00294	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CA—colon cancer	0.000106	0.00294	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000104	0.00289	CbGpPWpGaD
Cinacalcet—CYP3A4—renal system—colon cancer	0.000101	0.0352	CbGeAlD
Cinacalcet—CYP2D6—renal system—colon cancer	9.98e-05	0.0346	CbGeAlD
Cinacalcet—CASR—Signaling by GPCR—HRAS—colon cancer	9.8e-05	0.00272	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—AKT1—colon cancer	9.53e-05	0.00264	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CASP3—colon cancer	9.44e-05	0.00262	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCND1—colon cancer	9.19e-05	0.00255	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CTNNB1—colon cancer	9.1e-05	0.00252	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN1A—colon cancer	8.89e-05	0.00246	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	8.88e-05	0.00246	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—AKT1—colon cancer	8.66e-05	0.0024	CbGpPWpGaD
Cinacalcet—CYP1A2—liver—colon cancer	8.56e-05	0.0297	CbGeAlD
Cinacalcet—CASR—Signaling Pathways—EP300—colon cancer	8.46e-05	0.00234	CbGpPWpGaD
Cinacalcet—CYP3A4—digestive system—colon cancer	8.32e-05	0.0288	CbGeAlD
Cinacalcet—CASR—Signaling Pathways—SRC—colon cancer	8.23e-05	0.00228	CbGpPWpGaD
Cinacalcet—CYP2D6—digestive system—colon cancer	8.19e-05	0.0284	CbGeAlD
Cinacalcet—CYP3A4—Metabolism—CA7—colon cancer	8.18e-05	0.00227	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—colon cancer	8.01e-05	0.00222	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NRAS—colon cancer	7.92e-05	0.00219	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CHST5—colon cancer	7.58e-05	0.0021	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ODC1—colon cancer	7.58e-05	0.0021	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—colon cancer	7.37e-05	0.00204	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TGFB1—colon cancer	7.36e-05	0.00204	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGFR—colon cancer	7.21e-05	0.002	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KRAS—colon cancer	6.81e-05	0.00189	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CHST5—colon cancer	6.42e-05	0.00178	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ODC1—colon cancer	6.42e-05	0.00178	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CA—colon cancer	6.26e-05	0.00173	CbGpPWpGaD
Cinacalcet—CYP3A4—liver—colon cancer	6.2e-05	0.0215	CbGeAlD
Cinacalcet—CYP2D6—liver—colon cancer	6.1e-05	0.0211	CbGeAlD
Cinacalcet—CASR—Signaling Pathways—TP53—colon cancer	6.06e-05	0.00168	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HRAS—colon cancer	5.79e-05	0.0016	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKT1—colon cancer	5.11e-05	0.00142	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ODC1—colon cancer	4.96e-05	0.00137	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CHST5—colon cancer	4.96e-05	0.00137	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.65e-05	0.000734	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.09e-05	0.000578	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ABCB1—colon cancer	2e-05	0.000555	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TYMS—colon cancer	1.97e-05	0.000545	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.73e-05	0.000481	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ABCB1—colon cancer	1.7e-05	0.00047	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TYMS—colon cancer	1.67e-05	0.000462	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARG—colon cancer	1.39e-05	0.000386	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ABCB1—colon cancer	1.31e-05	0.000363	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TYMS—colon cancer	1.29e-05	0.000356	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.28e-05	0.000355	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARG—colon cancer	1.18e-05	0.000327	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—colon cancer	1.1e-05	0.000304	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—colon cancer	9.29e-06	0.000257	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—EP300—colon cancer	9.12e-06	0.000253	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARG—colon cancer	9.11e-06	0.000252	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—EP300—colon cancer	7.73e-06	0.000214	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—colon cancer	7.17e-06	0.000199	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CA—colon cancer	6.75e-06	0.000187	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—EP300—colon cancer	5.96e-06	0.000165	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CA—colon cancer	5.71e-06	0.000158	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKT1—colon cancer	5.51e-06	0.000153	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKT1—colon cancer	4.67e-06	0.000129	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CA—colon cancer	4.41e-06	0.000122	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKT1—colon cancer	3.6e-06	9.98e-05	CbGpPWpGaD
